RocketDNA Ltd. (ASX:RKT)

RocketDNA Statistics

Total Valuation

RocketDNA has a market cap or net worth of AUD 29.57 million. The enterprise value is 27.04 million.

Market Cap	29.57M
Enterprise Value	27.04M

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

RocketDNA has 1.18 billion shares outstanding. The number of shares has increased by 38.21% in one year.

Current Share Class	1.18B
Shares Outstanding	1.18B
Shares Change (YoY)	+38.21%
Shares Change (QoQ)	+7.65%
Owned by Insiders (%)	25.75%
Owned by Institutions (%)	1.03%
Float	753.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.85
PB Ratio	3.89
P/TBV Ratio	4.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.61
EV / Sales	3.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.29

Financial Position

The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.21.

Current Ratio	2.59
Quick Ratio	2.27
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	-0.50
Interest Coverage	-13.61

Financial Efficiency

Return on equity (ROE) is -41.02% and return on invested capital (ROIC) is -51.19%.

Return on Equity (ROE)	-41.02%
Return on Assets (ROA)	-17.30%
Return on Invested Capital (ROIC)	-51.19%
Return on Capital Employed (ROCE)	-31.77%
Weighted Average Cost of Capital (WACC)	6.84%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.78
Inventory Turnover	10.75

Taxes

Income Tax	-33,493
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +127.27% in the last 52 weeks. The beta is 0.44, so RocketDNA's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+127.27%
50-Day Moving Average	0.03
200-Day Moving Average	0.02
Relative Strength Index (RSI)	46.93
Average Volume (20 Days)	2,194,859

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RocketDNA had revenue of AUD 7.68 million and -2.82 million in losses. Loss per share was -0.00.

Revenue	7.68M
Gross Profit	3.37M
Operating Income	-2.73M
Pretax Income	-2.79M
Net Income	-2.82M
EBITDA	-1.53M
EBIT	-2.73M
Loss Per Share	-0.00

Balance Sheet

The company has 3.89 million in cash and 1.62 million in debt, with a net cash position of 2.27 million or 0.00 per share.

Cash & Cash Equivalents	3.89M
Total Debt	1.62M
Net Cash	2.27M
Net Cash Per Share	0.00
Equity (Book Value)	7.61M
Book Value Per Share	0.01
Working Capital	4.44M

Cash Flow

In the last 12 months, operating cash flow was -1.51 million and capital expenditures -1.75 million, giving a free cash flow of -3.26 million.

Operating Cash Flow	-1.51M
Capital Expenditures	-1.75M
Free Cash Flow	-3.26M
FCF Per Share	-0.00

Margins

Gross margin is 43.91%, with operating and profit margins of -35.56% and -36.64%.

Gross Margin	43.91%
Operating Margin	-35.56%
Pretax Margin	-36.36%
Profit Margin	-36.64%
EBITDA Margin	-19.86%
EBIT Margin	-35.56%
FCF Margin	n/a

Dividends & Yields

RocketDNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.21%
Shareholder Yield	-38.21%
Earnings Yield	-9.52%
FCF Yield	-11.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RocketDNA has an Altman Z-Score of 0.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.74
Piotroski F-Score	3